Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Use of Evidence-Based Prostate Cancer Imaging in a Nongovernmental Integrated Health Care System.

Salloum RG, O'Keeffe-Rosetti M, Ritzwoller DP, Hornbrook MC, Lafata JE, Nielsen ME.

J Oncol Pract. 2017 Feb 21:JOP2016018333. doi: 10.1200/JOP.2016.018333. [Epub ahead of print]

PMID:
28221895
2.

5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia.

Wallner LP, DiBello JR, Li BH, Van Den Eeden SK, Weinmann S, Ritzwoller DP, Abell JE, D'Agostino R Jr, Loo RK, Aaronson DS, Richert-Boe K, Horwitz RI, Jacobsen SJ.

Mayo Clin Proc. 2016 Dec;91(12):1717-1726. doi: 10.1016/j.mayocp.2016.07.023.

PMID:
28126151
3.

The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations.

Chubak J, Ziebell R, Greenlee RT, Honda S, Hornbrook MC, Epstein M, Nekhlyudov L, Pawloski PA, Ritzwoller DP, Ghai NR, Feigelson HS, Clancy HA, Doria-Rose VP, Kushi LH.

Cancer Causes Control. 2016 Nov;27(11):1315-1323.

PMID:
27639398
4.

Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer.

Menter AR, Carroll NM, Sakoda LC, Delate T, Hornbrook MC, Jain RK, Kushi LH, Quinn VP, Ritzwoller DP.

Clin Lung Cancer. 2017 Mar;18(2):189-197.e3. doi: 10.1016/j.cllc.2016.07.008.

PMID:
27637408
5.

Effectiveness and cost of influenza vaccine reminders for adults with asthma or chronic obstructive pulmonary disease.

Shoup JA, Madrid C, Koehler C, Lamb C, Ellis J, Ritzwoller DP, Daley MF.

Am J Manag Care. 2015 Jul 1;21(7):e405-13.

6.

Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer.

Carroll NM, Delate T, Menter A, Hornbrook MC, Kushi L, Aiello Bowles EJ, Loggers ET, Ritzwoller DP.

J Oncol Pract. 2015 Sep;11(5):356-62. doi: 10.1200/JOP.2014.002980.

7.

Adoption, reach, implementation, and maintenance of a behavioral and mental health assessment in primary care.

Krist AH, Phillips SM, Sabo RT, Balasubramanian BA, Heurtin-Roberts S, Ory MG, Johnson SB, Sheinfeld-Gorin SN, Estabrooks PA, Ritzwoller DP, Glasgow RE; MOHR Study Group..

Ann Fam Med. 2014 Nov-Dec;12(6):525-33. doi: 10.1370/afm.1710.

8.

Preventive care receipt and office visit use among breast and colorectal cancer survivors relative to age- and gender-matched cancer-free controls.

Lafata JE, Salloum RG, Fishman PA, Ritzwoller DP, O'Keeffe-Rosetti MC, Hornbrook MC.

J Cancer Surviv. 2015 Jun;9(2):201-7. doi: 10.1007/s11764-014-0401-3.

9.

Positron emission tomography and stage migration in head and neck cancer.

VanderWalde NA, Salloum RG, Liu TL, Hornbrook MC, O'Keeffe Rosetti MC, Ritzwoller DP, Fishman PA, Elston Lafata J, Khandani AH, Chera BS.

JAMA Otolaryngol Head Neck Surg. 2014 Jul;140(7):654-61. doi: 10.1001/jamaoto.2014.812.

PMID:
24875939
10.

Advanced imaging among health maintenance organization enrollees with cancer.

Loggers ET, Fishman PA, Peterson D, O'Keeffe-Rosetti M, Greenberg C, Hornbrook MC, Kushi LH, Lowry S, Ramaprasan A, Wagner EH, Weeks JC, Ritzwoller DP.

J Oncol Pract. 2014 Jul;10(4):231-8. doi: 10.1200/JOP.2013.001258.

11.

Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the cancer research network experience.

Ritzwoller DP, Carroll NM, Delate T, Hornbrook MC, Kushi L, Bowles EJ, Loggers ET, Menter A.

J Thorac Oncol. 2014 May;9(5):692-701. doi: 10.1097/JTO.0000000000000127.

12.

The influence of deductible health plans on receipt of the human papillomavirus vaccine series.

Roblin DW, Ritzwoller DP, Rees DI, Carroll NM, Chang A, Daley MF.

J Adolesc Health. 2014 Mar;54(3):275-81. doi: 10.1016/j.jadohealth.2013.12.001.

13.

Comparing cancer care, outcomes, and costs across health systems: charting the course.

Lipscomb J, Yabroff KR, Hornbrook MC, Gigli A, Francisci S, Krahn M, Gatta G, Trama A, Ritzwoller DP, Durand-Zaleski I, Salloum R, Chawla N, Angiolini C, Crocetti E, Giusti F, Guzzinati S, Mezzetti M, Miccinesi G, Mariotto A.

J Natl Cancer Inst Monogr. 2013;2013(46):124-30. doi: 10.1093/jncimonographs/lgt011. No abstract available.

14.

A standardized relative resource cost model for medical care: application to cancer control programs.

O'Keeffe-Rosetti MC, Hornbrook MC, Fishman PA, Ritzwoller DP, Keast EM, Staab J, Lafata JE, Salloum R.

J Natl Cancer Inst Monogr. 2013;2013(46):106-16. doi: 10.1093/jncimonographs/lgt002.

15.

The challenge of conducting comparative effectiveness research in cancer: the impact of a fragmented U.S. health-care system.

Fishman PA, Hornbrook MC, Ritzwoller DP, O'Keeffe-Rosetti MC, Lafata JE, Salloum RG.

J Natl Cancer Inst Monogr. 2013;2013(46):99-105. doi: 10.1093/jncimonographs/lgt008.

16.

Designing a valid randomized pragmatic primary care implementation trial: the my own health report (MOHR) project.

Krist AH, Glenn BA, Glasgow RE, Balasubramanian BA, Chambers DA, Fernandez ME, Heurtin-Roberts S, Kessler R, Ory MG, Phillips SM, Ritzwoller DP, Roby DH, Rodriguez HP, Sabo RT, Sheinfeld Gorin SN, Stange KC; MOHR Study Group..

Implement Sci. 2013 Jun 25;8:73. doi: 10.1186/1748-5908-8-73.

17.

Economic analyses of the Be Fit Be Well program: a weight loss program for community health centers.

Ritzwoller DP, Glasgow RE, Sukhanova AY, Bennett GG, Warner ET, Greaney ML, Askew S, Goldman J, Emmons KM, Colditz GA; Be Fit Be Well study investigators..

J Gen Intern Med. 2013 Dec;28(12):1581-8. doi: 10.1007/s11606-013-2492-3.

18.

Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts.

Hassett MJ, Ritzwoller DP, Taback N, Carroll N, Cronin AM, Ting GV, Schrag D, Warren JL, Hornbrook MC, Weeks JC.

Med Care. 2014 Oct;52(10):e65-73. doi: 10.1097/MLR.0b013e318277eb6f.

19.

When does an episode of care for cancer begin?

Hornbrook MC, Fishman PA, Ritzwoller DP, Elston-Lafata J, O'Keeffe-Rosetti MC, Salloum RG.

Med Care. 2013 Apr;51(4):324-9. doi: 10.1097/MLR.0b013e3182731277.

20.

Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network.

Ritzwoller DP, Carroll NM, Delate T, Hornbrook MC, Kushi L, Aiello Bowles EJ, Freml JM, Huang K, Loggers ET.

Lung Cancer. 2012 Dec;78(3):245-52. doi: 10.1016/j.lungcan.2012.09.008.

Supplemental Content

Loading ...
Support Center